These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25898134)

  • 1. Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.
    Paganin P; Fiscarelli EV; Tuccio V; Chiancianesi M; Bacci G; Morelli P; Dolce D; Dalmastri C; De Alessandri A; Lucidi V; Taccetti G; Mengoni A; Bevivino A
    PLoS One; 2015; 10(4):e0124348. PubMed ID: 25898134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.
    Sibley CD; Parkins MD; Rabin HR; Duan K; Norgaard JC; Surette MG
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15070-5. PubMed ID: 18812504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
    Stressmann FA; Rogers GB; van der Gast CJ; Marsh P; Vermeer LS; Carroll MP; Hoffman L; Daniels TW; Patel N; Forbes B; Bruce KD
    Thorax; 2012 Oct; 67(10):867-73. PubMed ID: 22707521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung function and microbiota diversity in cystic fibrosis.
    Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
    Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
    Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
    Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function.
    Al Shakirchi M; Klingspor L; Bergman P; Hjelte L; de Monestrol I
    Int J Infect Dis; 2020 Jul; 96():663-670. PubMed ID: 32450290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild Cystic Fibrosis Lung Disease Is Associated with Bacterial Community Stability.
    Hampton TH; Thomas D; van der Gast C; O'Toole GA; Stanton BA
    Microbiol Spectr; 2021 Sep; 9(1):e0002921. PubMed ID: 34232099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.
    da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA
    BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung microbiota across age and disease stage in cystic fibrosis.
    Coburn B; Wang PW; Diaz Caballero J; Clark ST; Brahma V; Donaldson S; Zhang Y; Surendra A; Gong Y; Elizabeth Tullis D; Yau YC; Waters VJ; Hwang DM; Guttman DS
    Sci Rep; 2015 May; 5():10241. PubMed ID: 25974282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.
    Gileles-Hillel A; Shoseyov D; Polacheck I; Korem M; Kerem E; Cohen-Cymberknoh M
    Pediatr Pulmonol; 2015 Nov; 50(11):1082-9. PubMed ID: 26383963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.
    Weiser R; Rye PD; Mahenthiralingam E
    J Microbiol Methods; 2021 Feb; 181():106133. PubMed ID: 33421446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
    Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
    PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J; McNally P; John B; DeSantis T; Linnane B; Murphy P;
    PLoS One; 2014; 9(12):e109798. PubMed ID: 25526264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
    Spasenovski T; Carroll MP; Payne MS; Bruce KD
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
    Delhaes L; Monchy S; Fréalle E; Hubans C; Salleron J; Leroy S; Prevotat A; Wallet F; Wallaert B; Dei-Cas E; Sime-Ngando T; Chabé M; Viscogliosi E
    PLoS One; 2012; 7(4):e36313. PubMed ID: 22558432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
    Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
    J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum Candida albicans presages FEV₁ decline and hospital-treated exacerbations in cystic fibrosis.
    Chotirmall SH; O'Donoghue E; Bennett K; Gunaratnam C; O'Neill SJ; McElvaney NG
    Chest; 2010 Nov; 138(5):1186-95. PubMed ID: 20472859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.